1045-196 Fiber type-specific angiogenic dysregulation in a genetic mouse model of heart failure  by Waters, Richard E et al.
458A ABSTRACTS - Vascular Disease, Hypertension, and Prevention JACC  March 3, 2004
Va
sc
ul
ar
 D
is
ea
se
, H
yp
er
te
ns
io
n,
 a
nd
 P
re
ve
nt
io
n
prevents the expected reduction in collateral flow after PCI of a stenotic vessel. There is a
direct dose-response relation between exercise capacity gained and coronary collateral
flow augmentation in the angiographically normal vessel.
1045-191 High-Density Lipoprotein-Induced Tube Formation 
Requires the Activation of Ras/Raf/Mitogen-Activated 
Protein Kinase in Human Coronary Artery Endothelial 
Cells
Shin-ichiro Miura, Masahiro Fujino, Hiroyuki Tanigawa, Yoshino Matsuo, Akira 
Kawamura, Hiroaki Nishikawa, Keijiro Saku, Fukuoka University School of Medicine, 
Fukuoka, Japan
Objectives: High density lipoprotein (HDL) levels have been shown to be inversely corre-
lated with coronary artery disease, but the mechanisms of the direct protective effect of
HDL on endothelial cells (ECs) are not fully understood. In this study, we investigated the
role of the HDL–mediated promotion of angiogenesis in human coronary artery ECs
(HCECs).
Methods and Results: We developed an in vitro model of HCEC tube formation on a
matrix gel. HDL induced tube formation, in which the dose-response showed that the
maximum effective dose of HDL was 100 µg/ml. We also examined the effect of sphin-
gosine-1-phosphate (S1P), which is a carrier of bioactive lipids of HDL, to analyze tube
formation. Since HDL contains S1P (about 180 pmol/mg protein), 100 µg/ml of HDL con-
tains about 0.018 µM of S1P. Although we observed 0.02 µM of S1P significantly induced
tube formation, it was only 20 % of 100 µg/ml HDL-induced tube formation. HDL-induced
tube formation may be partly mediated by S1P. PD98059, an inhibitor of p42/44 mitogen-
activated protein kinase (MAPK) activity, but not SB203580, an inhibitor of p38 MAPK
activity, suppressed HDL-induced tube formation. Dominant-negative Ras N17 inhibited
HDL-induced tube formation. HDL activated Ras by ras pull-down assay and its effect
was inhibited by pertusis toxin (PTX). Moreover, HDL activated phospho(p)-p42/44
MAPK, while Ras N17 blocked HDL-induced pp42/44 MAPK.
Conclusions: These results indicate that HDL induced a potent signal through a Ras/
MAPK pathway mediated by PTX-sensitive G-protein coupled receptor to the angiogenic
phenotype in HCECs.
1045-192 Monocytes, but Not Neutrophils or Lymphocytes Are 
Essential Mediators of Arteriogenesis
Sebastian Grundmann, Imo Hoefer, Niels van Royen, Stephan Schirmer, Susann 
Ulusans, Ivo Buschmann, University Hospital, Freiburg, Germany, Perfusion 
Technologies, Freiburg, Germany
Background: Blood vessel growth following arterial occlusion is mediated by infiltrating
leukocytes. While all three leukocyte subpopulations (neutrophils, lymphocytes, mono-
cytes) are known to play an important role in angiogenesis, only monocytes have been
shown to influence the growth of collateral arteries (arteriogenesis). In this study we
examined the importance of neutrophils and lymphocytes in a rabbit hindlimb model of
arteriogenesis. Methods: 36 Rabbits received either Interleukin-8 (IL-8), Neutrophil-acti-
vating-protein-2 (NAP-2) or Lymphotactin (Ltn) via osmotic minipumps directly into the
collateral circulation after femoral artery ligation. NAP-2 is a relatively selective activator
of neutrophils, Ltn chemoattracts lymphocytes and Il-8 has an effect on both celltypes.
PBS and MCP-1 treated groups served as controls. After one week, leukocytes around
growing collateral arteries were quantified via immunohistology and effects on integrin
markers of leukocytes activation (Mac-1, LFA-1) were assessed by flow-cytometry. Col-
lateral conductance was assessed using fluorescent microspheres. Results: Although a
significant increase in neutrophil accumulation after IL-8 and NAP-2 treatment was
detected in-vivo (cells/mm2: PBS:8,33±2,87,MCP-1:25,23±10,81,IL-8:36,06±12,65,NAP-
2:20,67±7,41,Ltn:8,27±5,44) and Il-8 and NAP-2 resulted in neutrophil activation in flow-
cytometry (Mac-1 Expression: PBS:21,12±2,11,MCP-1:24,11±2,64,IL-
8:32,65±2,10,NAP-2:27,30±2,25, Ltn:17,30±2,16), no significant increase in collateral
conductance was observed. Ltn treatment resulted in lymphocyte accumulation (cells/
mm2: PBS:2,48±1,24,MCP-1:4,26±1,16,IL-8:6,88±5,28,NAP-
2:2,70±0,57,Ltn:12,80±3,50), but not in collateral artery growth. Collateral conductance:
[ml/min/100mmHg]: PBS:50,70±5,15, MCP-1:339,60±19,6, IL-8:58,91±5,56, NAP-
2:66,83±8,72, Ltn:52,80±5,37. Conclusion: While lymphocytes and neutrophils are
known to participate in angiogenesis, their importance for arteriogenesis seems to be
neglectible. These findings support the hypothesis of monocytes/macrophages as key
mediators of collateral artery growth.
1045-193 Granulocyte-Colony Stimulating Factor Mobilizes and 
Activates Endothelial Progenitor Cells in Patients With 
Coronary Artery Disease
Tiffany M. Powell, Jonathan D. Paul, Jonathan M. Hill, Elizabeth J. Read, Philip J. McCoy, 
Richard O. Cannon, III, National Institutes of Health, Bethesda, MD
Background: Circulating endothelial progenitor cells may function to repair cardiovascu-
lar injury, but are reduced in patients with coronary artery disease. Granulocyte-colony
stimulating factor (G-CSF) mobilizes hematopoietic stem cells (CD34+) in healthy sub-
jects, but whether this cytokine mobilizes endothelial progenitor cells capable of endothe-
lial maturation in coronary artery disease patients is unknown. Methods: G-CSF (10
mcg/kg) was administered daily for 5 days to 12 coronary artery disease patients, and
circulating CD34+ cells, endothelial progenitor cells (CD133/ VEGFR-2+), and mature
endothelial cells [CD144 (VE-cadherin), CD31 (PECAM), CD51/61 (alphavbetaIII inte-
grin)] were measured by flow cytometry. Results: G-CSF increased CD34+ cells from <1
cell/microL of blood at baseline to 60±18 cells/microL within 24 hours of the last dose
(p<0.001), similar to CD34+ mobilization achieved in 28 healthy donors >40 years of age
at our hospital (78±8 cells/microL). Endothelial progenitor cells were also mobilized,
although to low levels (from <1 cell/microL at baseline to 6±3 cells/microL within 24 hours
of last G-CSF dose, p<0.001). Mature circulating endothelial cells also increased post-G-
CSF: CD34/CD144+ from 16±16 to 107±90 cells/microL, CD34/CD31+ from 54±28 to
224±60 cells/microL, CD34/CD51/61 from 14±14 to 81±64 cells/microL (all p<0.05 vs
baseline). One week following completion of treatment, CD34+ cells and endothelial pro-
genitor cells had returned to baseline, but levels of mature endothelial cells remained
increased over baseline (p<0.05). Conclusion: These findings establish that G-CSF
administration to coronary artery disease patients mobilizes CD34+ cells, which includes
the endothelial progenitor cell subset, into the circulation. Mobilization is associated with
increased cells expressing mature endothelial markers, which persist even at one week
following the last dose of G-CSF. This suggests sustained G-CSF-stimulated differentia-
tion along an endothelial cell lineage, with potential therapeutic implications for neovas-
cularization of ischemic myocardium.
1045-194 Impaired Arteriogenic Response to Acute Hindlimb 
Ischemia in CD8 Knockout Mice
Eugenio Stabile, Mary Susan Burnett, Timothy D. Kinnaird, Craig Watkins, Cheol W. Lee, 
Matie Shou, Andrea la Sala, Schmuel Fuchs, Stephen E. Epstein, Washington Hospital 
Center, Washington, DC
Background: CD8+ cytotoxic T lymphocytes regulate cellular responses of the immune
system, which play a pivotal role in modulating collateral vessel development.
The aim of our study was to investigate if the absence of circulating CD8+ T-cells impairs
collateral development after femoral artery ligation in CD8 -/- mice.
Methods and Results: After surgical excision of the femoral artery, Laser Doppler Perfu-
sion Imaging demonstrated reduced collateral flow induction in CD8 -/- mice compared to
control mice (C57BL/6J) at day 3 (0.21±0.01 vs 0.29±0.03, p< 0.01) which persisted to
day 28 (0.69±0.04 vs 0.90±0.04, p< 0.01). In CD8 -/- mice , when compared to controls,
the biological importance of the reduced collateral flow was evident by diminished recov-
ery of hindlimb function (ambulatory impairment score: 1.73 ± 0.18 vs 0.86 ± 0.19, p<
0.01), greater calf muscle atrophy (mean fiber area 767 ± 68 vs 1067 ± 69, µm2, p<
0.01), and increased fibrotic tissue content (14 ± 1% vs 7 ± 1%, p< 0.01). Exogenous
CD8+ T-cells, when infused into CD8-/- mice immediately after ischemia induction, selec-
tively home at the site of collateral formation and, over time, significantly increased collat-
eral flow, improved hindlimb functional recovery, and reduced muscle atrophy/fibrosis.
Conclusions: These results demonstrate that CD8+ T-cells are a critical component of
the immune system in regulating the early phase of normal collateral development. CD8 -
/- mice demonstrated both delayed and impaired blood flow recovery after femoral artery
ligation, and infusion of CD8+ T cells immediately after surgery rescued the phenotype.
Our study provides further evidence that the immune system is critical in modulating col-
lateral development in response to peripheral ischemia.
1045-195 Monocyte Chemoattractant Protein-1 Activates Vascular 
Endothelial Growth Factor- and Tumor Necrosis Factor-
Alpha-Mediated Angiogenesis in Ischemic Hindlimbs of 
Mice
Hiroshi Niiyama, Hisashi Kai, Hironobu Tahara, Toyoaki Murohara, Tsutomu Imaizumi, 
Kurume Univeristy, Kurume, Japan
Recently, we and others have suggested that macrophage accumulation plays a role in
angiogenesis in hindlimb ischemia model. Macrophage chemoattractant protein (MCP)-1
is a key molecule to trigger inflammatory changes in various diseases. Thus, we sought
to determine the role of the endogenous MCP-1 in ischemia-induced angiogenesis. At
day 0, unilateral hindlimb ischemia was induced by excising surgically entire left femoral
artery and vein in mice. Immediately after operation, plasmid DNA encoding 7ND, a dom-
inant negative mutant of MCP-1, or the empty plasmid (as control) was injected into the
ipsilateral thigh adductor muscle. Serial laser Doppler blood flow analysis showed an
abrupt decrease in blood flow, followed by a remarkable recovery, in ischemic hindlimbs
of controls. Control mice showed well-developed collateral vessels and capillary forma-
tion as assessed by postmortem angiography and immunohistostaining for CD31,
respectively, at day 21 after induction of ischemia. In 7ND-treated mice, although the
extent of the early decrease in laser Doppler blood flow was similar to that in controls, the
recovery was impaired. At day 3, macrophage infiltration and inductions of vascular
endothelial growth factor (VEGF) and tumor necrosis factor (TNF)-alpha, known angio-
genic factors, were prominent in the adductor muscle of ischemic hindlimbs in controls.
7ND treatment significantly reduced the number of infiltrated macrophages and
repressed VEGF and TNF-alpha inductions in response to ischemia at day 3. Moreover,
the number of angiographically visible collateral vessels and the capillary density were
significantly decreased in ischemic hindlimbs of 7ND-treated mice at day 21. In conclu-
sion, MCP-1-mediated macrophage accumulation may play an important role in
ischemia-induced angiogenesis at least in part by activating induction of angiogenic fac-
tors such as VEGF and TNF-alpha in ischemic hindlimbs.
1045-196 Fiber Type-Specific Angiogenic Dysregulation in a 
Genetic Mouse Model of Heart Failure
Richard E. Waters, II, Brian Annex, Zhen Yan, Duke University Medical Center, Durham, 
NC
Introduction. Chronic heart failure (CHF) leads to intrinsic skeletal muscle abnormalities
including slow-oxidative to fast-glycolytic fiber type switching, decreased capillary den-
sity, and reduced mitochondrial function. These skeletal muscle abnormalities contribute
to clinical exercise intolerance. Methods. A genetic mouse model of heart failure induced
through cardiac-targeted overexpression of the sarcoplasmic reticulum Ca2+ storage pro-
tein calsequestrin (CSQ) has been recently characterized. Skeletal muscle (plantaris)
from CSQ/CHF mice and wild type (WT) mice was analyzed with triple color immunof-
lourescence using antibodies specific for myosin heavy chain I, IIa, IIb, and endothelial
cells. Results. A decrease in oxidative myofibers (I + IIa), a concurrent increase in glyco-
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lytic myofibers (IIb + IIx), and an overall decrease in capillary density was observed in
CSQ/CHF mice compared to WT littermates. Analysis of fiber type-specific capillary den-
sity revealed an increase in type IIa myofiber capillary density and a concomitant
decrease in type IIb + IIx myofiber capillary density in the CSQ/CHF mice. Conclusion.
These results suggest that chronic heart failure causes skeletal muscle fiber type switch-
ing and dysregulation of angiogenesis in a fiber type-specific manner. Furthermore,
these results support the use of the CSQ/CHF mouse model to further study the role of
skeletal muscle maladaptation in chronic heart failure and to explore potential therapeutic
targets.
1045-197 Evidence for Hypoxia and Hypoxia-Inducible Factor-1-
Alpha Mediated Vascular Endothelial Growth Factor 
Expression in Lipid-Rich Plaque Macrophages as Link 
Between Inflammation and Angiogenesis
Randolph Hutter, Carolina Valdiviezo, Bernhard Sauter, Roberto Corti, Gurusher 
Panjrath, Francine Carrick, John T. Fallon, Valentin Fuster, Juan Jose Badimon, Mount 
Sinai School of Medicine, New York, NY
Background: Macrophages expressing the pro-angiogenic factor VEGF can contribute to
plaque progression and vulnerability via induction of intimal neovascularization. Hypoxia
Inducible Factor 1-alpha (HIF-1 alpha) has been identified as key transcriptional regulator
of cellular VEGF-synthesis and mediates the angiogenic response of tissues to hypoxia.
However, little is known about the pattern of expression of HIF-1 alpha in atherosclerosis.
Our objective was to assess in parallel the expression of HIF-1 alpha and VEGF in
human and experimental atherosclerosis comparing lipid-rich with fibrous plaque.
Methods: In human atheroma (n=12) HIF-1 alpha and VEGF mRNA and protein expres-
sion were evaluated by in situ hybridization and immunohistochemistry (data presented
as mean±SEM). In NZW-rabbits (n=14) atherosclerotic lesions were induced by aortic
double balloon injury and 9 months of high-cholesterol (HC) diet. Five rabbits were sacri-
ficed at 9 months and were used as baseline (BL). The remaining rabbits were then ran-
domized into continued HC diet (n=5) and normal chow diet (ND) (n=4) for another 6
months. Total serum cholesterol at the end of ND treatment was 27±10 mg/dl vs.
861±143 mg/dl at BL (P<.01) and 526±108 mg/dl with continued HC-diet at 15 months
(P<.01).
Results: In human atheroma, HIF-1 alpha and VEGF mRNA and protein expression were
increased in lipid-rich compared to fibrous plaque (23±5 % vs. 5±2 %, P<.01; 32±6 % vs.
8±3 %, P<.05) and correlated with high macrophage and neovessel content (P<.05).
Double-labeling demonstrated co-localization of HIF-1 alpha and VEGF in inflammatory
cells surrounding intimal neovessels in close proximity to cholesterol clefts. In plaques of
rabbits with continued HC diet and high serum lipid levels expression of both HIF-1 alpha
and VEGF-protein as assessed by immunohistochemistry and Western Blot were signifi-
cantly increased compared to BL and ND.
Conclusions: The selective detection of HIF-1 alpha in VEGF-expressing macrophages
located in lipid-rich plaque tissue points to hypoxia as a possible link between inflamma-
tion and angiogenesis. Both processes might synergistically contribute to plaque pro-
gression and vulnerability.
1045-198 Influence of Diabetes Mellitus on Coronary Collateral 
Flow: A Definite Answer to a Rather Elderly Controversy
Rainer Zbinden, Stefan Zbinden, Michael Billinger, Stefan Windecker, Bernhard Meier, 
Christian Seiler, Cardiovascular Center Bern, Bern, Switzerland
Background: The influence of diabetes mellitus (DM) on coronary collateral flow is con-
troversial. This may be due to the use of inaccurate means of measuring collateral flow
(i.e. angiographic assessment), another reason relates to differences in parameters influ-
encing collateral flow between diabetic and nondiabetic patients (serum lipids, severity of
coronary artery disease (CAD)). The purpose of this study was to determine the influ-
ence of DM on coronary collateral flow in a large population with variable degrees of CAD
using accurate means of collateral flow measurement.
Methods: 187 patients (age 63 +/- 9 years; 86 diabetic and 101 nondiabetic patients)
were included in the study. Coronary collateral flow was assessed in 196 stenotic and in
38 angiographically normal vessels using a pressure guide wire (n=145), Doppler guide
wire (n=53) or both (n=36) to calculate pressure- or flow-velocity-derived collateral flow
index (CFI). Diabetic patients were matched for gender, age, serum lipids and percent
diameter stenosis of the vessel undergoing CFI measurement with a nondiabetic control
group.
Results: The two groups were exactly balanced for clinical and angiographic data. There
was no difference between CFI in the diabetic versus the non-diabetic patients (0.205 ±
0.119 and 0.217 ± 0.128; p=NS). There was still no difference in CFI when only angio-
graphically normal vessels (0.193 ± 0.084 and 0.201 ± 0.072; p=NS) or chronic total cor-
onary occlusions (0.314 ± 0.151 and 0.323 ± 0.186; p=NS) were compared. There was a
trend towards a lower number of patients having angina pectoris during the one-minute
vessel occlusion in the diabetic group (p = 0.1). There was no correlation between the
CFI and the level of HbA1c (as marker for blood glucose control over the last 2-3
months).
Conclusion: There is no difference in coronary collateral flow between diabetic and non-
diabetic patients. There is no inverse “dose-response” relation between blood glucose
control (represented by the HbA1c level) and coronary collateral flow. There is a trend
that diabetic patients have less angina pectoris during a one minute balloon occlusion
than non-diabetic patients.
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1046-165 Measurement of Resting Ankle Brachial Index May Not 
Accurately Identify Disease in Patients With Signs or 
Symptoms of Peripheral Arterial Disease
Ingrid Hriljac, Jeffrey W. Olin, Victoria Teodorescu, Susan M. Gustavson, Jonathan L. 
Halperin, Mount Sinai Medical Center, New York, NY
Background: The ankle-brachial index (ABI) is useful for objective assessment of lower
extremity arterial perfusion, correlating with symptoms and functional severity of periph-
eral arterial disease (PAD) in population-based studies. This simple, inexpensive mea-
surement can be performed in the primary care office for detection of PAD, and is a
marker of increased cardiovascular risk in both symptomatic and asymptomatic patients.
The diagnostic accuracy of the resting ABI in patients with symptoms or signs of PAD,
however, has not been determined. Methods: In order to determine the added diagnostic
utility of measuring ABI and pulse volume waveforms (PVR) at rest and after exercise, we
analyzed the results of 142 consecutive patients who were referred to the vascular labo-
ratory by non-vascular specialists between February and September 2003. Results: The
average patient age was 68 years; 54% were male. Resting ABI was normal in 44%,
abnormal in 38% and not diagnostic due to arterial calcification in 17%. Forty percent
were abnormal in those with claudication, 45% in those with ulceration and 28% in those
with rest pain. Thirty-six (57%) patients with a normal ABI underwent treadmill exercise
testing and 28% of these were found to have an abnormal exercise study indicating the
presence of PAD. Among the 24 patients (17%) with calcified vessels, 5 (21%) had
abnormal PVR consistent with PAD. Conclusion: In symptomatic patients with normal
resting ABI, PAD was diagnosed frequently by measuring ABI after exercise. Of the 17%
in whom arterial calcification precluded accurate ABI measurement, PVR disclosed PAD
in 21%. In patients with suspected PAD, referral to a vascular laboratory for exercise test-
ing and PVR offers more precise diagnosis than office measurements of ABI.
1046-166 Is the Application of Collagen-Based Vascular Closure 
Devices After Percutaneous Coronary Interventions 
Safe and Effective? Intermediate Results From the 
Prospective Bad Berka Registry
Marc-Alexander Ohlow, Hügl Burkhard, Karsten Reinig, Hubertus von Korn, Bernward 
Lauer, Zentralklinik Bad Berka, Bad Berka, Germany
Background: Several vascular closure devices (VCD) were developed as an alternative
for manual compression after percutaneous interventions (PCI) of the coronary arteries
to reduce the time to discharge. We report about the results of the collagen based VCD
VasoSeal®ES™ (Datascope Corp.) [VS] and Angio-Seal® (St. Jude Medical) [AS].
Methods: From 10/01 to 09/02 patients with collagen based VCD after percutaneous
interventions were enrolled in our prospective registry. During the intervention heparin,
aspirin and if necessary clopidogrel were administered. The two VCD were used accord-
ing to a standardized method, the choice of the device after PCI was left to the discretion
of the investigator. Secondary haemorrhage, haematomas (> 5 cm diameter), pseudoan-
eurysms and AV fistulae were noted as complications. A clinical examination and a
Duplex examination in addition was performed routinely at every patient.
Results: 5717 cardiac catheterisations were done until deadline 31.09.2002.
In 1170 cases a VCD was used after coronary intervention, 700 times AS and 470 times
VS. One of the above described complications appeared at 54 of 700 cases (7.71%) in
the AS group, in the VS group in 35 of 470 cases (7.44 %.) The predominant number of
the complications fell on minor complications such as haematoma and smaller secondary
haemorrhages (49 of 54 at AS group (7%) and 30 of 35 at VS group (6,4%). Only 5 of 54
(0,7%) of AS and in 5 of 35 (1%) of VS developed more serious complications. One
patient in the AS group developed an AV fistula, in four cases we saw pseudoaneurysms.
5 cases of the VS group developed pseudoaneurysms. All aneurysms could be success-
fully compressed in an ultrasound guided procedure. In one patient of the VS group the
